Pricing Log in Create free account

Fractyl Health, Inc. (GUTS) vs RenovoRx, Inc. (RNXT)

Fractyl Health, Inc. and RenovoRx, Inc. are both Biotechnology companies. Fractyl Health, Inc. and RenovoRx, Inc. are of similar size ($55.2M and $53.7M). Fractyl Health, Inc. has the higher net margin (0.00% vs −621.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, RenovoRx, Inc. leads on 8 and Fractyl Health, Inc. on 6.

Valuation

Metric GUTS RNXT Biotechnology median
P/E n/m n/m 8.50
P/S 2,644.15 27.53 9.71
P/B n/m 6.06 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 2,464.64 25.16 9.21
Earnings yield (56.77%) (26.96%) (33.15%)
Free cash flow yield (33.75%) (21.95%) (25.50%)

Profitability

Metric GUTS RNXT Biotechnology median
Gross margin 46.24% 84.41% 65.16%
Operating margin 0.00% (685.22%) 0.00%
Net margin 0.00% (621.71%) 0.00%
Free cash flow margin 0.00% (604.10%) 0.00%
Return on equity 1,063.04% (125.23%) (56.36%)
Return on assets (146.75%) (97.83%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GUTS RNXT Biotechnology median
Revenue growth (TTM) (22.50%) — 6.02%
EPS growth (last fiscal year) (14.81%) 20.00% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GUTS RNXT Biotechnology median
Debt to equity (18.29) 0.00 0.00
Current ratio 3.15 5.74 4.72
Net debt to EBITDA 0.53 0.56 0.96

Dividend

Metric GUTS RNXT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric GUTS RNXT Biotechnology median
Market cap 55.18m 53.71m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack